(Q34230516)

31 July 2017

title

An international survey of reported prescribing practice in the treatment of patients with generalised anxiety disorder (English)

1 reference

31 July 2017

Borwin Bandelow

3

0 references

author name string

David S Baldwin

1

1 reference

31 July 2017

Christer Allgulander

2

1 reference

31 July 2017

Francisco Ferre

4

1 reference

31 July 2017

Stefano Pallanti

5

1 reference

31 July 2017

publication date

7 November 2011

1 reference

World Journal of Biological Psychiatry

31 July 2017

published in

1 reference

31 July 2017

volume

13

1 reference

31 July 2017

issue

7

1 reference

31 July 2017

page(s)

510-516

1 reference

Prevalence and impact of generalized anxiety disorder and major depression in primary care in Belgium and Luxemburg: the GADIS study.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.624548

Room for improvement in the pharmacological treatment of anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.624548

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.624548

Evidence-based pharmacological treatment of generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.624548

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.624548

Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.624548

Rethinking the duration requirement for generalized anxiety disorder: evidence from the National Comorbidity Survey Replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.624548

The epidemiology of generalized anxiety disorder in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.624548

A brief measure for assessing generalized anxiety disorder: the GAD-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.624548

Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.624548

Generalized anxiety disorder: prevalence, burden, and cost to society.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.624548

Clinician recognition of anxiety disorders in depressed outpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.624548

10.3109/15622975.2011.624548

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference